Rubicon Research gets one US FDA Form 483 observation after Satara plant inspection

admin
October 9, 2026
Uncategorized

Rubicon Research’s Satara manufacturing facility received one procedural observation in Form 483 following an unannounced US FDA inspection conducted from October 5 to 9.

Leave a ReplyCancel Reply